MedPath

LYNPARZA 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

LYNPARZA 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

114959004

Prescription Type

Diagnóstico Hospitalario

Authorization Date

May 27, 2018

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number114959004
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

OLAPARIBActive
Quantity: 150 mg
Name: OLAPARIB

ATC CLASSIFICATION (3)

L01X
L01XK
L01XK01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.